1. Twin drug design, synthesis and evaluation of diosgenin derivatives as multitargeted agents for the treatment of vascular dementia
- Author
-
Jia-Min Sun, Xing-Xing Diao, Lu-Lu Zheng, Rui Wang, Haixian Gan, Yan Huang, Jin Huang, Yun Tang, Li Zhang, Lei Ma, Jie Li, and Gui-Xiang Yang
- Subjects
Male ,Antioxidant ,Cell Survival ,NF-E2-Related Factor 2 ,medicine.medical_treatment ,Clinical Biochemistry ,Pharmaceutical Science ,Diosgenin ,Pharmacology ,Protective Agents ,01 natural sciences ,Biochemistry ,Neuroprotection ,Steroid ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Memory ,In vivo ,Drug Discovery ,medicine ,Animals ,Humans ,Learning ,Vascular dementia ,Molecular Biology ,Cholinesterase ,Mice, Inbred ICR ,Kelch-Like ECH-Associated Protein 1 ,biology ,010405 organic chemistry ,Chemistry ,Dementia, Vascular ,Organic Chemistry ,medicine.disease ,KEAP1 ,0104 chemical sciences ,Molecular Docking Simulation ,010404 medicinal & biomolecular chemistry ,Acetylcholinesterase ,biology.protein ,Molecular Medicine ,Cholinesterase Inhibitors ,Reactive Oxygen Species ,Central Nervous System Agents ,Protein Binding - Abstract
A novel series of multitargeted molecules were designed and synthesized by combining the pharmacological role of cholinesterase inhibitor and antioxidant of steroid as potential ligands for the treatment of Vascular Dementia (VD). The oxygen-glucose deprivation (OGD) model was used to evaluate these molecules, among which the most potent compound ML5 showed the highest activity. Firstly, ML5 showed appropriate inhibition of cholinesterases (ChEs) at orally 15 mg/kg in vivo. The further test revealed that ML5 promoted the nuclear translocation of Nrf2. Furthermore, ML5 has significant neuroprotective effect in vivo model of bilateral common carotid artery occlusion (BCCAO), significantly increasing the expression of Nrf2 protein in the cerebral cortex. In the molecular docking research, we predicted the ML5 combined with hAChE and Keap1. Finally, compound ML5 displayed normal oral absorption and it was nontoxic at 500 mg/kg, po, dose. We can draw the conclusion that ML5 could be considered as a new potential compound for VD treatment.
- Published
- 2021
- Full Text
- View/download PDF